Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | yes | yes: 4 |
Forrest at al. (procyclic) | yes | yes: 4 |
Silverman et al. | no | yes: 2 |
Pissara et al. | yes | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I1Q0
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 3 |
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004127 | cytidylate kinase activity | 6 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0005524 | ATP binding | 5 | 3 |
GO:0016301 | kinase activity | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 |
GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 4 | 3 |
GO:0017076 | purine nucleotide binding | 4 | 3 |
GO:0019205 | nucleobase-containing compound kinase activity | 5 | 3 |
GO:0030554 | adenyl nucleotide binding | 5 | 3 |
GO:0032553 | ribonucleotide binding | 3 | 3 |
GO:0032555 | purine ribonucleotide binding | 4 | 3 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 3 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 3 |
GO:0036094 | small molecule binding | 2 | 3 |
GO:0043167 | ion binding | 2 | 3 |
GO:0043168 | anion binding | 3 | 3 |
GO:0050145 | nucleoside monophosphate kinase activity | 5 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:0097367 | carbohydrate derivative binding | 2 | 3 |
GO:1901265 | nucleoside phosphate binding | 3 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 183 | 187 | PF00656 | 0.486 |
CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.335 |
CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.450 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.475 |
CLV_PCSK_KEX2_1 | 268 | 270 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.500 |
CLV_PCSK_PC1ET2_1 | 169 | 171 | PF00082 | 0.475 |
CLV_PCSK_PC1ET2_1 | 43 | 45 | PF00082 | 0.548 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.326 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.482 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.261 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.592 |
DEG_SCF_FBW7_1 | 198 | 205 | PF00400 | 0.395 |
DOC_AGCK_PIF_1 | 136 | 141 | PF00069 | 0.324 |
DOC_CKS1_1 | 199 | 204 | PF01111 | 0.416 |
DOC_MAPK_DCC_7 | 254 | 264 | PF00069 | 0.457 |
DOC_MAPK_MEF2A_6 | 51 | 60 | PF00069 | 0.368 |
DOC_MAPK_RevD_3 | 255 | 269 | PF00069 | 0.334 |
DOC_PP1_RVXF_1 | 124 | 131 | PF00149 | 0.345 |
DOC_PP1_RVXF_1 | 167 | 174 | PF00149 | 0.359 |
DOC_PP2B_LxvP_1 | 257 | 260 | PF13499 | 0.472 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.508 |
DOC_USP7_UBL2_3 | 293 | 297 | PF12436 | 0.372 |
DOC_WW_Pin1_4 | 198 | 203 | PF00397 | 0.449 |
DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.326 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.533 |
LIG_14-3-3_CanoR_1 | 137 | 142 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 170 | 174 | PF00244 | 0.422 |
LIG_14-3-3_CanoR_1 | 242 | 247 | PF00244 | 0.316 |
LIG_BIR_III_2 | 122 | 126 | PF00653 | 0.424 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.350 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.474 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.421 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.350 |
LIG_FHA_1 | 86 | 92 | PF00498 | 0.366 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.456 |
LIG_FHA_2 | 213 | 219 | PF00498 | 0.350 |
LIG_LIR_Gen_1 | 138 | 147 | PF02991 | 0.295 |
LIG_LIR_Gen_1 | 178 | 185 | PF02991 | 0.358 |
LIG_LIR_Gen_1 | 233 | 239 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 138 | 142 | PF02991 | 0.284 |
LIG_LIR_Nem_3 | 233 | 238 | PF02991 | 0.453 |
LIG_SH2_CRK | 139 | 143 | PF00017 | 0.319 |
LIG_SH2_CRK | 235 | 239 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.381 |
LIG_SUMO_SIM_anti_2 | 261 | 266 | PF11976 | 0.384 |
LIG_TRAF2_1 | 287 | 290 | PF00917 | 0.555 |
LIG_TRAF2_1 | 83 | 86 | PF00917 | 0.433 |
LIG_UBA3_1 | 104 | 113 | PF00899 | 0.410 |
MOD_CDC14_SPxK_1 | 251 | 254 | PF00782 | 0.333 |
MOD_CDK_SPxK_1 | 248 | 254 | PF00069 | 0.320 |
MOD_CDK_SPxxK_3 | 69 | 76 | PF00069 | 0.516 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.478 |
MOD_CK2_1 | 212 | 218 | PF00069 | 0.352 |
MOD_CK2_1 | 284 | 290 | PF00069 | 0.516 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.384 |
MOD_CK2_1 | 80 | 86 | PF00069 | 0.416 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.384 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.505 |
MOD_GlcNHglycan | 283 | 287 | PF01048 | 0.592 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.503 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.440 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.363 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.395 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.391 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.418 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.357 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.473 |
MOD_NEK2_1 | 203 | 208 | PF00069 | 0.574 |
MOD_NEK2_1 | 282 | 287 | PF00069 | 0.575 |
MOD_PIKK_1 | 212 | 218 | PF00454 | 0.346 |
MOD_PIKK_1 | 240 | 246 | PF00454 | 0.394 |
MOD_PKA_1 | 169 | 175 | PF00069 | 0.480 |
MOD_PKA_2 | 169 | 175 | PF00069 | 0.480 |
MOD_Plk_1 | 155 | 161 | PF00069 | 0.385 |
MOD_Plk_2-3 | 157 | 163 | PF00069 | 0.504 |
MOD_Plk_2-3 | 284 | 290 | PF00069 | 0.499 |
MOD_Plk_4 | 137 | 143 | PF00069 | 0.321 |
MOD_Plk_4 | 169 | 175 | PF00069 | 0.435 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.361 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.334 |
MOD_ProDKin_1 | 198 | 204 | PF00069 | 0.441 |
MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.320 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.533 |
MOD_SUMO_for_1 | 174 | 177 | PF00179 | 0.392 |
TRG_DiLeu_BaLyEn_6 | 199 | 204 | PF01217 | 0.502 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.301 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.333 |
TRG_NES_CRM1_1 | 247 | 263 | PF08389 | 0.422 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1G0 | Leptomonas seymouri | 79% | 100% |
A0A0S4IKR6 | Bodo saltans | 55% | 100% |
A0A1X0NZI5 | Trypanosomatidae | 59% | 100% |
A0A3S7WZD1 | Leishmania donovani | 100% | 100% |
A0A422P4M6 | Trypanosoma rangeli | 58% | 100% |
A4HEA4 | Leishmania braziliensis | 87% | 100% |
C9ZKA2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 99% |
E9AXT4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q4Q9N7 | Leishmania major | 98% | 100% |
V5BMH9 | Trypanosoma cruzi | 57% | 100% |